The ‘beige book’ survey of regional conditions showed a subdued economy facing inflation and little or modest growth.
Incyte Biosciences Canada today announced that Health Canada has approved Opzelura® (ruxolitinib (as ruxolitinib phosphate)) ...
Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback